iPSC Core Facility Helmholtz Zentrum München
Establishment of the iPSC Core Facility
The human induced Pluripotent Stem Cell Core Facility of the Helmholtz Center in Munich (Helmholtz Zentrum München; HMGU) was founded end of 2012 within the Institute of Stem Cell Research (Institut für Stammzellforschung; ISF).
Dr. Micha Drukker, PhD is the Director and research associate Dr. Anna Pertek is heading the activities in the Unit.
The mission of the Core Facility is to provide knowledge-base and expertise for researchers interested in working with human pluripotent stem cells (PSCs). The activity of the Core Facility consists of four elements: i) reprogramming of somatic cells and supplying established human iPS cell lines to investigators, ii) developing and optimizing reprogramming technologies, iii) collaborating with scientists at the HMGU and around the globe, and iv) differentiating human iPS cells for disease modeling and for drug discovery purposes.